Proteocyte AI, Toronto, ON (2026)

02/24/2026

At Proteocyte AI, quality is embedded in everything we do.

From training and technology development to clinical procedures and services, our work is guided by a robust Quality Management System (QMS) and stringent regulatory standards.

Our commitment ensures reliable results, clinical confidence, and continued innovation—because our patients and partners deserve nothing less than our best.

American Dental Association Beacon Oral & Maxillofacial Surgeons Everyday Oral Surgery Head and Neck Cancer Alliance Osteo Science Foundation Oral Cancer Foundation Paradigm Oral Health

02/17/2026

Ordering STRATICYTE® is simple, secure, and fully supported by Proteocyte AI Client Services.

👉 Complete Test Request Form: https://proteocyte.com/ordering-options/
📄 Submit order: 📧 Email: clientservices@proteocyte.com or 📠 Fax: 1-855-566-0488
📞 Questions? 📧 clientservices@proteocyte.com or 📱 1-833-577-6836

✔️ Secures payment from clinic or patient
✔️ Obtains unstained slides from the original OPMD biopsy lab
✔️ Facilitates specimen transfer to our lab*
✔️ Delivers the STRATICYTE® report in ~2–3 weeks from specimen receipt*

*Proprietary AI biomarker analysis and H&E and digitized image analysis performed at Proteocyte AI labs

US Lab Director: Dr. Paras Patel | CA Lab Director: Dr. Ken Pritzker

Canadian Dental Association Canadian Partnership Against Cancer Société de recherche sur le cancer / Cancer Research Society Fondation québécoise du cancer Manitoba Dental Association NB Dental Society Newfoundland and Labrador Dental Association

02/10/2026

📄 New Research Supporting Predictive Biomarkers in OPMDs

A peer-reviewed study highlights S100A7 as a promising predictive biomarker for identifying oral potentially malignant disorders (OPMDs) at increased risk of transforming into oral squamous cell carcinoma (OSCC).

The study demonstrates that S100A7 expression—evaluated through immunohistochemistry and a signature risk algorithm—can differentiate transforming from non-transforming lesions with statistical significance.

This research reinforces the role of biomarker-driven, objective risk assessment in advancing oral cancer prediction and patient care.

🔗 Explore our publications: https://proteocyte.com/publications/

Alberta Dental Association Association des chirurgiens dentistes du Québec - ACDQ BC Cancer Foundation BC Dental Association CancerCare Manitoba Canadian Association of Oral and Maxillofacial Surgeons Canadian Cancer Society

02/03/2026

Oral cancer can develop in any part of the mouth, including the lips, gums, tongue, and palate.

This year alone, over 50,000 North Americans will be diagnosed—and 1 in 5 cases will be fatal.

Despite advances in medicine, 5-year survival remains ~50%, and survival rates have seen little improvement over the past 30+ years.

Early detection and prediction are critical for improving outcomes.

That’s why STRATICYTE® helps predict oral cancer risk—supporting earlier, more informed patient management when it matters most.

To learn more about STRATICYTE®, visit www.proteocyte.com.

Alberta Dental Association Association des chirurgiens dentistes du Québec - ACDQ BC Cancer Foundation BC Dental Association CancerCare Manitoba Canadian Association of Oral and Maxillofacial Surgeons Canadian Cancer Society

01/29/2026

Who is Proteocyte AI?

Proteocyte AI is a privately owned med-tech company based on Hospital Row in downtown Toronto, with labs in Canada and the US, dedicated to advancing how cancer risk is identified and managed. Our focus is developing cutting-edge diagnostic lab tests that use proteomic assays and AI-driven analysis to predict a patient’s future risk of developing cancer.

By identifying patients at high risk earlier, Proteocyte AI empowers clinicians to make more informed decisions and tailor patient management more effectively.

STRATICYTE® is our transformative test that has received clinical accreditation in both Canada and the USA. Designed specifically for oral cancer prediction, STRATICYTE® provides objective, personalized 5-year risk assessment to support earlier detection and better outcomes.

At Proteocyte AI, we’re committed to shaping the future of cancer prognostics—one innovation at a time.

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation FoundationOral Health Foundation events

01/28/2026

Join Proteocyte at the AAOM Winter Meeting!

Proteocyte is proud to sponsor AAOM’s Winter Meeting on January 31, 2026—a live webinar focused on the oral–systemic connection and current best practices in oral medicine. We’re pleased to offer our community 10% off registration—use code 10PROTEOCYTE at checkout. Learn more and register: https://site.pheedloop.com/event/2026AAOMWinter/home

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
Cancer Foundation Foundation Health Foundation events

01/27/2026

Oral cancer is on the rise—and unlike many cancers, its impact reaches far beyond health.

Our speech, nutrition, and identity are all tied to the mouth and face. When patients develop oral or head-and-neck cancer, the consequences are life-altering.

STRATICYTE® represents the next era of testing.

With objective, AI-driven prognostic insight, STRATICYTE® helps clinicians better understand and manage oral potentially malignant lesions, supporting earlier intervention and improved patient outcomes.

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/20/2026

Meet our Principal US Lab Director, Dr. Paras Patel, DDS. Dr. Patel is a board certified oral and maxillofacial pathologist, who obtained his dental degree from Howard University College of Dentistry and went on to complete his residency in Oral and Maxillofacial Pathology from (Baylor) College of Dentistry.

Upon completion of his residency, Dr. Patel took a position at the college of dentistry as a full-time faculty member. After 5 years in academia, he transitioned to private practice and established the Center for Oral Pathology, where he clinically manages patients with a wide variety of oral diseases.

He also had the opportunity to continue his practice of surgical pathology in conjunction with ProPath, where he was instrumental in establishing the division of oral and maxillofacial pathology, where he currently serves as director. Dr. Patel also stays active in clinical research involving oral potentially malignant disorders/precancerous lesions and oral cancer.

"I grew up in a humanitarian-driven healthcare environment and believe that patients come first. In a field where there have been no advances in diagnostics as well as treatment and management, I feel it is my obligation to make a difference. I have personally and professionally seen what this disease does to the individuals afflicted, and am adamant that we as a community do something to change the future."

Learn more: https://proteocyte.com/team/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/15/2026

Did you know the global 5-year survival rate for oral cancer is only ~50%?

And nearly 70% of cases aren’t diagnosed until Stage 3 or 4—when treatment becomes far more complex and outcomes decline.

In North America alone, oral cancer takes one life every hour.

Oral cancer often begins as a precancerous lesion, which can appear anywhere in the mouth—on the lips, cheeks, tongue, gums, or palate. These lesions may show up as red, white, or mixed-colour patches. They often don’t hurt, don’t heal, and may go unnoticed until spotted during a routine dental exam.

To determine whether a lesion is a precancer (an OPMD), a biopsy is needed. This tissue sample is reviewed by a pathologist under the microscope through a process called histopathology.

That’s where STRATICYTE® can make a critical difference.

Using AI-driven biomarker analysis and digital pathology, STRATICYTE® supplements traditional histopathology by providing an objective, personalized 5-year oral cancer risk score.

Your STRATICYTE® report will clearly classify your lesion as low risk or elevated risk, giving your healthcare professional the clarity needed to make more confident, evidence-based decisions about your care.

Early detection saves lives. And having accurate risk information helps ensure timely intervention for high-risk patients while reducing unnecessary treatment for those at lower risk.

Ask your healthcare provider about STRATICYTE®.

Learn more: https://proteocyte.com/straticyte/patients/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/13/2026

We want to hear from you.

In this update, Dr. Paras Patel invites clinicians to share their STRATICYTE® experience—how the test is supporting more objective evaluation, clearer guidance, and better education for patients with OPMDs.

From provider feedback to patient stories, STRATICYTE® is helping bring clarity to what each patient should do next in managing their lesion.

Have insights to share? Join the conversation.

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/06/2026

We are thrilled to kick off 2026 by extending the PAISIP (Proteocyte AI Shared Innovation Program) offer to Jan 31, 2026!

2025 was a landmark year for Proteocyte AI, marked by widespread North American adoption of the STRATICYTE® test and a pivotal advance in oral cancer risk prediction. Now is the time to build on this momentum to deliver even better patient outcomes and create lasting change in how oral cancer risk is detected and managed and we invite you to join us on this journey.

✅ Get early OSCC prediction
✅ Give patients a 5-year window to OSCC risk

Our Offer: Increase OSCC detection + prediction. Proactively manage oral precancer patients

Our Ask: Order the test and share feedback on the process, the report, and its utility

For precision and peace of mind, go beyond standard in 2026 and order the STRATICYTE ® test. Together, we can improve oral precancer patient care and outcomes .

Contact us to learn more: clientservices@proteocyte.com
https://proteocyte.com/about/contact/

Order STRATICYTE® : https://proteocyte.com/ordering-options/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Health Foundation events

12/19/2025

📄 What’s included in a STRATICYTE® report?

STRATICYTE® is supported by over a decade of clinical research and robust clinical validation which continues to be strengthened by ongoing studies with major oral pathology centres in North America.

Each STRATICYTE® report provides:

✔️ A personalized 5-year cancer risk score
✔️ Clear classification of low vs. elevated risk

This comprehensive insight helps clinicians confidently manage oral precancer patients with evidence-based precision.

👉 Watch this short video to learn about this novel test: https://www.youtube.com/watch?v=m7boEYIsQpk

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

Proteocyte AI

02/24/2026

02/17/2026

02/10/2026

02/03/2026

01/29/2026

01/28/2026

01/27/2026

01/20/2026

01/15/2026

01/13/2026

01/06/2026

12/19/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category